Free Trial

Acumen Pharmaceuticals (ABOS) Insider Trading & Ownership

→ AI “wealth window” is closing June 25th (From Paradigm Press) (Ad)
Free abos Stock Alerts
$3.56
+0.07 (+2.01%)
(As of 05/6/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Acumen Pharmaceuticals (NASDAQ:ABOS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$40.00 M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$382,384.76
Get ABOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ABOS Insider Buying and Selling by Quarter

Ad InvestorPlace
Watch this FREE trading tutorial while it’s still available
On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.
Click here for details.

Acumen Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/19/2024Daniel Joseph OconnellCEOSell15,200$3.47$52,744.00  
1/19/2024Derek M MeisnerInsiderSell8,933$3.48$31,086.84  
1/18/2024Matt ZugaCFOSell4,242$3.71$15,737.82  
1/18/2024Russell BartonCOOSell2,833$3.73$10,567.09  
8/17/2023Jeffrey L. IvesDirectorSell41,949$6.49$272,249.01  
7/21/2023Ra Capital Management, L.P.DirectorBuy5,161,290$7.75$39,999,997.50  
(Data available from 1/1/2013 forward)

ABOS Insider Trading Activity - Frequently Asked Questions

Who is on Acumen Pharmaceuticals's Insider Roster?

The list of insiders at Acumen Pharmaceuticals includes Daniel Joseph Oconnell, Derek M Meisner, Jeffrey L. Ives, John A Stalfort III, Matt Zuga, Paul B Manning, Ra Capital Management, L.P., and Russell Barton. Learn more on insiders at ABOS.

What percentage of Acumen Pharmaceuticals stock is owned by insiders?

7.50% of Acumen Pharmaceuticals stock is owned by insiders. Learn more on ABOS's insider holdings.

Which Acumen Pharmaceuticals insiders have been buying company stock?

The following insider purchased ABOS shares in the last 24 months: Ra Capital Management, L.P. ($39,999,997.50).

How much insider buying is happening at Acumen Pharmaceuticals?

Insiders have purchased a total of 5,161,290 ABOS shares in the last 24 months for a total of $39,999,997.50 bought.

Which Acumen Pharmaceuticals insiders have been selling company stock?

The following insiders have sold ABOS shares in the last 24 months: Daniel Joseph Oconnell ($52,744.00), Derek M Meisner ($31,086.84), Jeffrey L. Ives ($272,249.01), Matt Zuga ($15,737.82), and Russell Barton ($10,567.09).

How much insider selling is happening at Acumen Pharmaceuticals?

Insiders have sold a total of 73,157 Acumen Pharmaceuticals shares in the last 24 months for a total of $382,384.76 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ABOS) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners
No experience to confident trader, meet my student…
Wealth Builders Institute
Biden’s $374B Giveaway Into This Sector
DTI
AI “wealth window” is closing June 25th
Paradigm Press
Oil Surge Predicted... But Are You Ready
The Oxford Club
Make this ONE trade on Tuesday at 2 p.m. EST!
Monument Traders Alliance
The 2024 crypto bull run has already started — don’t get left behind
InvestorPlace
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
The asset beating inflation by 4x
Colonial Metals